Virtual ACC 2020 | More data from ISCHEMIA: Women with More Symptoms but Less Ischemia

The ISCHEMIA trial will keep shedding light. The latest data show important differences between men and women as regards disease severity and its correlation with symptoms. Women have more angina than men but have less extensive ischemia. 

ACC 2020 Virtual | Más datos del ISCHEMIA: mujeres con más síntomas pero con menos isquemia

These findings were presented virtually at the ACC 2020, cancelled by COVID19, and suggest that, in addition to obstructive coronary artery disease, other factors might play a role. 

Why do women show more symptoms? A reductive point of view claims they have a different pain threshold, but there might be other factors at play. There are several interesting hypotheses (especially suitable for quarantine) from differences in myocardial innervation to differences in endothelial function, and microvascular function. A few studies even suggest emotional stress most likely is what triggers ischemia in women and this would not be associated to obstructive CAD severity. 


Read also: Virtual ACC 2020 | COMPASS Sub-Analysis: Diabetes Increases the Benefit of Rivaroxaban Combined with AAS.


Whatever the answer, something is obvious: women behave differently compared to men when it comes to ischemia and symptoms. At first glance, there is nothing striking about this old information. However, this outdated information had multiple confounders that the ISCHEMIA study does not have. 

The ISCHEMIA randomized 5179 patients to an invasive strategy of coronary angiography followed by revascularization, when needed, plus optimal medical treatment vs. an initial conservative strategy vs. optimal medical treatment alone. 

Patients were randomized prior angiography and blinded coronary CT angiography that ruled out left main disease (or any disease of comparable severity), while confirming the presence of CAD. 


Read also: Virtual ACC 2020 | More Evidence in Support of the Demanding 2017 Hypertension Guidelines.


Out of 2262 women and 6256 men evaluated (not all were randomized, hence the difference in n), women more often presented non obstructive CAD vs. men (34% vs 11%; p<0.001). Obstructive CAD was defined as lesions of at least 50% stenosis in any epicardial vessel. Seeing as one of the inclusion criteria of this study was the presence of obstructive CAD, it included far fewer women. 

In the randomized cohort, women presented less ischemia in the stress imaging, a difference driven by patients undergoing nuclear stress imaging. The echo stress test did not show significant differences in ischemia severity between both sexes. 

Despite the less amount of obstructive CAD and the less severe results by nuclear stress imaging, women referred significantly more symptoms. Compared against 37% of men, only 27% of women claimed to be symptom free (p<0.001). On multivariable analysis, female sex resulted an independent predictor of angina (OR 1.41; 95% CI 1.13-1.76). 

Original Title: Sex differences in severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: insights from the ISCHEMIA trial.

Reference: Reynolds HR et al. ACC 2020 virtual. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...